Genmab A/S Foreign Exchange Gain
Genmab A/S (GNMSF) reported Foreign Exchange Gain of $158.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Income Statement › Other Income
ifrs-full:ForeignExchangeGain · last filed 2026-02-17
DKK
| Period end | Foreign Exchange Gain 6 month | Foreign Exchange Gain 12 month |
|---|---|---|
| 2024-12-31 | 1.34B DKK 6-K · filed 2025-02-12 | |
| 2024-06-30 | 729.00M DKK 6-K · filed 2024-08-08 | |
| 2023-12-31 | 889.00M DKK 6-K · filed 2025-02-12 | |
| 2023-06-30 | 1.04B DKK 6-K · filed 2024-08-08 | |
| 2022-12-31 | 1.03B DKK 6-K · filed 2024-02-14 | |
| 2021-12-31 | 1.47B DKK 6-K · filed 2024-02-14 |
USD
| Period end | Foreign Exchange Gain 12 month |
|---|---|
| 2025-12-31 | $158.00M 20-F · filed 2026-02-17 |
| 2024-12-31 | $258.00M 20-F · filed 2026-02-17 |
| 2023-12-31 | $0.00 20-F · filed 2026-02-17 |